Market Overview:
The global peptide APIs market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for peptide-based drugs for the treatment of various diseases such as cancer, diabetes, obesity, fertility, and others. In addition, the growing focus on R&D activities by pharmaceutical companies is also contributing to the growth of this market. Based on type, the global peptide APIs market can be segmented into liquid phase peptide synthesis (LPPS) and solid phase peptide synthesis (SPPS). LPPS is a more traditional method used for synthesizing small proteins and has been in use since early 1960s. SPPS is a more recent technique that was developed in mid-1970s and offers several advantages over LPPS such as shorter reaction time, higher purity products, better reproducibility etc. Based on application, the global peptide APIs market can be segmented into cancer therapy & diagnostics; diabetes therapy & diagnostics; obesity therapy & diagnostics; fertility therapy & diagnostics; other therapeutic areas including cardiovascular diseases (CVD), central nervous system disorders (CNS), respiratory disorders etc.; and research applications.
Product Definition:
Peptide APIs are important for creating drugs that can interact with the body's peptide receptors. These APIs can help to modulate the activity of peptides in the body, which can have a therapeutic effect. Peptides are often used to target specific areas of the body, making them an important tool for drug development.
Liquid Phase Peptide Synthesis (LPPS):
The global liquid phase peptide synthesis market size was valued at USD 5.0 billion in 2016 and is expected to grow at a CAGR of XX% over the forecast period. Liquid-phase Peptide Abundance (LPPS) process is recognized as a cost-effective, high throughput method for large-scale production of recombinant proteins with improved yields and purity compared to conventional solid-phase procedures.
Solid Phase Peptide Synthesis (SPPS):
Solid Phase Peptide Synthesis (SPPS) is a process of making large quantities of high-quality peptides by combining amino acids in the presence of chiral catalysts. The product obtained is called “Peptide” which consists of unique combinations and sequences of amino acids that have been optimized for specific applications. SPPS has wide applications in pharmaceuticals, nutraceuticals, cosmetics, food & beverages and other industries.
Application Insights:
The cancer segment dominated the global peptide APIs market in terms of revenue share in 2017. The growing prevalence of cancer and increasing demand for targeted therapeutics are some of the major factors driving this segment. For instance, according to data published by WHO, it has been estimated that globally around 1 in 6 women and 1 in 5 men are diagnosed with some form of cancer during their lifetime. Moreover, as per estimates from the American Cancer Society, around 2 million new cases were reported worldwide in 2018 and about 90% of these cases were due to tumor growth due to genetic mutations caused due to ionizing radiation exposure or non-exposure (throughout lifetime). This is expected to drive product demand over the forecast period.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a substantial number of peptide developers and pharmaceutical companies. Moreover, increasing R&D activities by various organizations is expected to fuel growth over the forecast period. The U.S.
Asia Pacific region is anticipated to witness lucrative growth during the forecast period due to rising healthcare expenditure and growing awareness about peptide-based drug therapies among patients in this region.
Growth Factors:
- Increasing demand for peptide-based drugs for the treatment of various diseases
- Growing research and development activities in the field of peptide therapeutics
- Rising number of collaborations and partnerships between pharmaceutical companies and biotechnology firms to develop novel peptide-based drugs
- Proliferation of clinical studies on peptide-based therapies for various indications
- increasing investments by pharmaceutical companies in the development of novel peptide-based drugs
Scope Of The Report
Report Attributes
Report Details
Report Title
Peptide APIs Market Research Report
By Type
Liquid Phase Peptide Synthesis (LPPS), Solid Phase Peptide Synthesis (SPPS)
By Application
Cancer, Diabetes, Obesity, Fertility, Other
By Companies
CordenPharma, PolyPeptide, Bachem, AmbioPharm, Pepscan, BCN Peptides, Senn Chemicals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Peptide APIs Market Report Segments:
The global Peptide APIs market is segmented on the basis of:
Types
Liquid Phase Peptide Synthesis (LPPS), Solid Phase Peptide Synthesis (SPPS)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cancer, Diabetes, Obesity, Fertility, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- CordenPharma
- PolyPeptide
- Bachem
- AmbioPharm
- Pepscan
- BCN Peptides
- Senn Chemicals
Highlights of The Peptide APIs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Liquid Phase Peptide Synthesis (LPPS)
- Solid Phase Peptide Synthesis (SPPS)
- By Application:
- Cancer
- Diabetes
- Obesity
- Fertility
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Peptide APIs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Peptide APIs are a type of software that allow developers to create custom applications that can access and manipulate peptides. Peptide APIs can be used to develop tools for research, drug discovery, and other scientific purposes.
Some of the key players operating in the peptide apis market are CordenPharma, PolyPeptide, Bachem, AmbioPharm, Pepscan, BCN Peptides, Senn Chemicals.
The peptide apis market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Peptide APIs Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Peptide APIs Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Peptide APIs Market - Supply Chain
4.5. Global Peptide APIs Market Forecast
4.5.1. Peptide APIs Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Peptide APIs Market Size (000 Units) and Y-o-Y Growth
4.5.3. Peptide APIs Market Absolute $ Opportunity
5. Global Peptide APIs Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Peptide APIs Market Size and Volume Forecast by Type
5.3.1. Liquid Phase Peptide Synthesis (LPPS)
5.3.2. Solid Phase Peptide Synthesis (SPPS)
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Peptide APIs Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Peptide APIs Market Size and Volume Forecast by Application
6.3.1. Cancer
6.3.2. Diabetes
6.3.3. Obesity
6.3.4. Fertility
6.3.5. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Peptide APIs Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Peptide APIs Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Peptide APIs Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Peptide APIs Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Peptide APIs Demand Share Forecast, 2019-2026
9. North America Peptide APIs Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Peptide APIs Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Peptide APIs Market Size and Volume Forecast by Application
9.4.1. Cancer
9.4.2. Diabetes
9.4.3. Obesity
9.4.4. Fertility
9.4.5. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Peptide APIs Market Size and Volume Forecast by Type
9.7.1. Liquid Phase Peptide Synthesis (LPPS)
9.7.2. Solid Phase Peptide Synthesis (SPPS)
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Peptide APIs Demand Share Forecast, 2019-2026
10. Latin America Peptide APIs Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Peptide APIs Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Peptide APIs Market Size and Volume Forecast by Application
10.4.1. Cancer
10.4.2. Diabetes
10.4.3. Obesity
10.4.4. Fertility
10.4.5. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Peptide APIs Market Size and Volume Forecast by Type
10.7.1. Liquid Phase Peptide Synthesis (LPPS)
10.7.2. Solid Phase Peptide Synthesis (SPPS)
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Peptide APIs Demand Share Forecast, 2019-2026
11. Europe Peptide APIs Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Peptide APIs Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Peptide APIs Market Size and Volume Forecast by Application
11.4.1. Cancer
11.4.2. Diabetes
11.4.3. Obesity
11.4.4. Fertility
11.4.5. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Peptide APIs Market Size and Volume Forecast by Type
11.7.1. Liquid Phase Peptide Synthesis (LPPS)
11.7.2. Solid Phase Peptide Synthesis (SPPS)
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Peptide APIs Demand Share, 2019-2026
12. Asia Pacific Peptide APIs Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Peptide APIs Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Peptide APIs Market Size and Volume Forecast by Application
12.4.1. Cancer
12.4.2. Diabetes
12.4.3. Obesity
12.4.4. Fertility
12.4.5. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Peptide APIs Market Size and Volume Forecast by Type
12.7.1. Liquid Phase Peptide Synthesis (LPPS)
12.7.2. Solid Phase Peptide Synthesis (SPPS)
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Peptide APIs Demand Share, 2019-2026
13. Middle East & Africa Peptide APIs Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Peptide APIs Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Peptide APIs Market Size and Volume Forecast by Application
13.4.1. Cancer
13.4.2. Diabetes
13.4.3. Obesity
13.4.4. Fertility
13.4.5. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Peptide APIs Market Size and Volume Forecast by Type
13.7.1. Liquid Phase Peptide Synthesis (LPPS)
13.7.2. Solid Phase Peptide Synthesis (SPPS)
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Peptide APIs Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Peptide APIs Market: Market Share Analysis
14.2. Peptide APIs Distributors and Customers
14.3. Peptide APIs Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. CordenPharma
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. PolyPeptide
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Bachem
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. AmbioPharm
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Pepscan
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. BCN Peptides
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Senn Chemicals
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
